Table 9.
Name | Formation |
Growth |
||||
---|---|---|---|---|---|---|
ΔfG⁰Battley (kJ/C-mol) | ΔfG⁰Roels (kJ/C-mol) | Relative deviation | ΔrG⁰Battley (kJ/C-mol) | ΔrG⁰Roels (kJ/C-mol) | Relative deviation | |
SARS-CoV-2: Entire virus | -24.84 | -24.17 | -2.7% | -6.9 | -6.2 | -9.7% |
SARS-CoV-2: Nucleocapsid | -33.73 | -33.85 | 0.4% | -222.2 | -222.4 | 0.1% |
MERS: Entire virus | -24.28 | -23.52 | -3.1% | -7.5 | -6.7 | -10.2% |
MERS: Nucleocapsid | -32.26 | -32.22 | -0.1% | -208.5 | -208.4 | 0.0% |
SARS-1: Entire virus | -24.68 | -24.05 | -2.5% | -6.5 | -5.9 | -9.6% |
SARS-1: Nucleocapsid | -33.46 | -33.64 | 0.5% | -230.3 | -230.5 | 0.1% |
Lung - parenchyma | -24.94 | -25.37 | 1.7% | -49.8 | -50.2 | 0.9% |